Aurora Spine Corporation
ASAPF
$0.20
$0.000.51%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.05% | 10.24% | 10.05% | 16.27% | 20.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.05% | 10.24% | 10.05% | 16.27% | 20.70% |
| Cost of Revenue | -8.13% | 10.84% | 21.23% | 13.33% | 18.34% |
| Gross Profit | -6.35% | 9.88% | 3.16% | 18.52% | 22.30% |
| SG&A Expenses | -2.50% | 8.83% | 8.41% | 37.94% | 16.49% |
| Depreciation & Amortization | 2.32% | 32.76% | -10.55% | -10.47% | -19.09% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.17% | 10.42% | 10.71% | 20.42% | 12.13% |
| Operating Income | -164.80% | -16.94% | -22.67% | -90.89% | 157.34% |
| Income Before Tax | -299.72% | -29.01% | -31.02% | -128.54% | 128.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -299.72% | -29.01% | -31.02% | -128.54% | 128.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -299.72% | -29.01% | -31.02% | -128.54% | 128.49% |
| EBIT | -164.80% | -16.94% | -22.67% | -90.89% | 157.34% |
| EBITDA | -70.60% | 287.16% | -2,111.36% | -949.27% | 1,909.23% |
| EPS Basic | -300.00% | -30.00% | -32.35% | -121.05% | 125.00% |
| Normalized Basic EPS | -250.00% | -16.67% | -13.64% | -66.67% | 126.09% |
| EPS Diluted | -300.00% | -30.00% | -32.35% | -121.05% | 125.00% |
| Normalized Diluted EPS | -250.00% | -16.67% | -13.64% | -66.67% | 126.09% |
| Average Basic Shares Outstanding | 0.60% | 0.55% | 0.50% | 3.46% | 12.10% |
| Average Diluted Shares Outstanding | 0.60% | 0.55% | 0.50% | 3.46% | 12.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |